Congress speakers OT 2021

Dutch Veterinary Oncology Conference, the virtual experience!

These are our speakers:

Prof. dr. Arjan Griffioen

Professor of Experimental Oncology and Angiogenesis, Head Angiogenesis Laboratory

Director of the Graduate School for Oncology Amsterdam (OOA)

I am working on making a vaccine for therapy and prevention of cancer. I am a professor of cancer biology specialized in tumor immunology and angiogenesis at Amsterdam UMC. With my team, the Angiogenesis Laboratory, we are focusing on vaccines that target the tumor vasculature. This approach is effective and safe and does not induce drug resistance. We are currently bringing the first vaccine into clinical testing.
Next to my practical research activities I have the following functions:
Director of the Graduate School for Oncology Amterdam (OOA)
Director of the Master Oncology program at the VU University Amterdam
Editor-in-Chief of the scientific journal Angiogenesis
Founder and Chief Scientific Officer of CimCure BV 


Prof. dr. Henrik Rönnberg

Prof, DECVIM-CA(onc), Deputy Dean at the Faculty of Vet Medicine and Animal Science at Swedish Univ of Agricultural Sciences, Uppsala.


Dr. Gerry Polton

MA VetMB MSc (Onc) DipECVIM (Oncology) MRCVS, RCVS Specialist in Veterinary Oncology, EBVS® European Veterinary Specialist in Small Animal Oncology

Gerry graduated from Cambridge Veterinary School in 1997, after which he initially worked in first opinion practice. He entered specialist practice as a clinical oncologist in 2002. Gerry was awarded a Master of Science degree in clinical oncology by the Institute of Cancer Research at Birmingham University in 2003, having presented a thesis on the subject of canine anal sac tumours, a subject on which he is a world expert.

He became a Diplomate of the European College of Veterinary Internal Medicine and a European recognised Specialist in Oncology in 2010 and an RCVS recognised Specialist in Oncology in 2012.

Gerry has published scientific literature and lectured across the world on a range of cancer subjects including lymphoma, mast cell tumours, lung tumours, insulin-producing tumours and novell anti-cancer therapies; he chairs and participates in a number of European oncology research projects and has a particular interest in collaborative clinical research. Gerry is Director of the Oncology Service at North Downs Specialist Referrals.